Home » Topics » BioWorld Science

BioWorld Science
RSS

LogicBio Therapeutics begins program for genome-editing therapy for methylmalonic acidemia

May 11, 2018

Gilead studies GS-9688 in virally suppressed patients with chronic HBV infection

May 10, 2018

YL Biologics and Kyowa submit Japanese NDA for etanercept biosimilar YLB-113

May 10, 2018

FDA grants orphan drug designation to Cellectar's CLR-131 for rhabdomyosarcoma

May 10, 2018

Sellas' galinpepimut-S awarded FDA orphan drug designation for multiple myeloma

May 10, 2018

MediciNova cleared to study ibudilast for glioblastoma

May 10, 2018

Astellas licenses rights to Aquinox's rosiptor in Japan and Asia-Pacific countries

May 10, 2018

Forma Therapeutics collaborates with University of Oxford on deubiquitinating enzyme inhibitors

May 10, 2018

Phase III study of Tecentriq and Cotellic in metastatic colorectal cancer misses primary endpoint

May 10, 2018

CSIC, University of Glasgow present trypanosomal alternative oxidase inhibitors

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...